Access for Life's vision is to facilitate therapies that require repetitive vein access for chronic disease patients, with the first market for dialysis.  Our patented platform of the JEM™ implanted sensor-enhanced device, preserves vein health while it reduces the rate of clinical complications due to vessel wall damage. It provides for the first time, real-time data collection on the dialysis process.  The JEM™ platform ensures easier and safer cannulation, thereby greatly encouraging self-cannulation and home hemodialysis.

© 2020 by Access for Life. Proudly created with Wix.com

  • LinkedIn Basic Black
  • Twitter Basic Black